In reports with patient data, elevated CENP-A levels prognosticate poor patient survival for cancers (Zhang et al., 2016; Saha et al., 2020) and patient outcome after chemotherapy (Zhang et al., 2016). The gene discussed is CENPA; the disease is cancer.